|9 Months Ended|
Sep. 30, 2022
NOTE 20 - SUBSEQUENT EVENTS
As of November 11, 2022, the Company issued an aggregate of 4,745 shares of its common stock for consulting services and one employee valued at $8,875.
As of November 11, 2022, the Company has: (i) entered into one sales distribution agreement for UnCraveRx Weight Loss Program (ii) entered into one purchase agreement for the Beat Addiction Recovery Program (iii) entered into one employee stock agreement.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef